Literature DB >> 19719781

Stimulation of cardiac beta-adrenoceptors targets connexin 43.

Kerstin Boengler1.   

Abstract

Connexin 43 (Cx43) is the major protein of cardiac ventricular gap junctions and is crucial to cell-cell communication and cardiac function. The protein level of Cx43 is reduced in patients with heart failure or dilated cardiomyopathy (DCM), pathophysiological conditions often associated with arrhythmias. As catecholamines are often increased in cardiac diseases, Salameh et al., in this issue of the BJP, investigated the effect of beta-adrenoceptor stimulation of neonatal cardiomyocytes on Cx43 expression and found increased Cx43 mRNA and protein levels following 24 h stimulation. Up-regulation of Cx43 was associated with phosphorylation of mitogen-activated protein kinases and translocation of transcription factors into the nucleus. In patients with DCM, a situation often associated with desensitization of the beta-adrenoceptor system, Cx43 expression was reduced. The characterization of the signal transduction pathways involved in Cx43 expression and intracellular localization in human myocardium in vivo is a promising target for the development of new anti-arrhythmic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719781      PMCID: PMC2795258          DOI: 10.1111/j.1476-5381.2009.00372.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

Review 1.  Cardiac gap junction channels: modulation of expression and channel properties.

Authors:  A A van Veen; H V van Rijen; T Opthof
Journal:  Cardiovasc Res       Date:  2001-08-01       Impact factor: 10.787

2.  Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia.

Authors:  M A Beardslee; D L Lerner; P N Tadros; J G Laing; E C Beyer; K A Yamada; A G Kléber; R B Schuessler; J E Saffitz
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

Review 3.  Plasma membrane channels formed by connexins: their regulation and functions.

Authors:  Juan C Saez; Viviana M Berthoud; Maria C Branes; Agustin D Martinez; Eric C Beyer
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

4.  Altered connexin expression in human congestive heart failure.

Authors:  E Dupont; T Matsushita; R A Kaba; C Vozzi; S R Coppen; N Khan; R Kaprielian; M H Yacoub; N J Severs
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

5.  Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning.

Authors:  Kerstin Boengler; Giuliano Dodoni; Antonio Rodriguez-Sinovas; Alberto Cabestrero; Marisol Ruiz-Meana; Petra Gres; Ina Konietzka; Carmen Lopez-Iglesias; David Garcia-Dorado; Fabio Di Lisa; Gerd Heusch; Rainer Schulz
Journal:  Cardiovasc Res       Date:  2005-08-01       Impact factor: 10.787

6.  The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth.

Authors:  Xitong Dang; Bradley W Doble; Elissavet Kardami
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

7.  Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A.

Authors:  Xun Ai; Steven M Pogwizd
Journal:  Circ Res       Date:  2004-12-02       Impact factor: 17.367

8.  Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo.

Authors:  Rainer Schulz; Petra Gres; Andreas Skyschally; Alexej Duschin; Sergej Belosjorow; Ina Konietzka; Gerd Heusch
Journal:  FASEB J       Date:  2003-05-20       Impact factor: 5.191

Review 9.  Structural bases for the chemical regulation of Connexin43 channels.

Authors:  Mario Delmar; Wanda Coombs; Paul Sorgen; Heather S Duffy; Steven M Taffet
Journal:  Cardiovasc Res       Date:  2004-05-01       Impact factor: 10.787

10.  c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes.

Authors:  Brian G Petrich; Xiaohua Gong; Deborah L Lerner; Xin Wang; Joan Heller Brown; Jeffrey E Saffitz; Yibin Wang
Journal:  Circ Res       Date:  2002-10-04       Impact factor: 17.367

View more
  4 in total

1.  GPCR theme editorial.

Authors:  G Milligan; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

2.  Bilirubin Improves Gap Junction to Alleviate Doxorubicin-Induced Cardiotoxicity by Regulating AMPK-Axl-SOCS3-Cx43 Axis.

Authors:  Siqi Zhang; Yixin Fan; Binbin Zheng; Yu Wang; Chen Miao; Yue Su; Kun Li; Yan E; Xueli Wang; Xueming He; Xuefeng Wu; Chenjie Xu; Yulin Tang; Wen-Tao Liu; Xiangqing Kong; Liang Hu
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

3.  Systemic maternal inflammation and neonatal hyperoxia induces remodeling and left ventricular dysfunction in mice.

Authors:  Markus Velten; Kirk R Hutchinson; Matthew W Gorr; Loren E Wold; Pamela A Lucchesi; Lynette K Rogers
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

4.  Rictor/mTORC2 involves mitochondrial function in ES cells derived cardiomyocytes via mitochondrial Connexin 43.

Authors:  Jia-Dan Wang; Ying Shao; Dan Liu; Nuo-Ya Liu; Dan-Yan Zhu
Journal:  Acta Pharmacol Sin       Date:  2021-02-05       Impact factor: 7.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.